SARS-CoV-2 Assessment of Viral Evolution Collaborating Institutions

Federal Agencies and Laboratories

  • Centers for Disease Control and Prevention (CDC)
  • Food and Drug Administration, Center for Biologics Evaluation and Research (FDA)
  • Biomedical Advanced Research and Development Authority (BARDA)
  • Los Alamos National Laboratory (LANL)
  • NIAID, National Institutes of Health, Division of Microbiology, and Infectious Diseases (NIAID, DMID)
  • NIAID, National Institutes of Health, Integrated Research Facility-Frederick  (NIAID, IRF)
  • NIAID, National Institutes of Health, Vaccine Research Center (NIAID, VRC)
  • NIAID, National Institutes of Health, Rocky Mountain Laboratories (NIAID, RML)
  • Walter Reed Army Institute of Research (WRAIR)

Academic Institutions

  • Ben-Gurion University
  • Beth Israel Deaconess Medical Center
  • Broad Institute
  • Columbia University
  • Duke University Medical Center
  • Emory University School of Medicine
  • Erasmus University Medical Center
  • Fred Hutchinson Cancer Research Center
  • Harvard Medical School
  • Johns Hopkins Bloomberg School of Public Health
  • Icahn School of Medicine at Mount Sinai
  • J. Craig Venter Institute
  • La Jolla Institute for Immunology
  • New York University
  • Ragon Institute
  • Seattle Children’s Research Institute
  • St. Jude Children’s Research Hospital
  • Texas Biomedical Research Institute
  • University of California at Riverside
  • University of Cambridge
  • University of Hong Kong
  • University of Iowa
  • University of Maryland
  • University of Michigan
  • University of Tennessee Health Science Center
  • University of Texas Medical Branch
  • University of the Western Cape
  • University of Wisconsin- Madison
  • Washington University in St. Louis


  • American Type Culture Collection (ATCC), BEI Resources


Content last reviewed on